期刊文献+

急性冠状动脉综合征患者血清超敏C反应蛋白及抵抗素浓度与罪犯病变虚拟组织学-血管内超声特点的相关性 被引量:9

Relationship between plasma resistin and high-sensitivity C reactive protein and the virtual histology intravascular ultrasound characters of culprit lesions in ACS patients
下载PDF
导出
摘要 目的通过分析急性冠状动脉综合征(ACS)患者血清超敏C反应蛋白及抵抗素浓度与罪犯病变虚拟组织学-血管内超声(VH-IVUS)特点相关性,研究血清超敏C反应蛋白及抵抗素影响斑块易损性的机制。方法选取ACS患者60例,运用酶联免疫分析法(ELISA法)检测血清抵抗素浓度及血清超敏C反应蛋白浓度。结合心电图检查ST-T发生改变的导联,超声心动图出现室壁运动异常的节段以及冠状动脉造影发现复杂病变的部位确定罪犯病变。从而研究ACS患者血清抵抗素及超敏C反应蛋白浓度与ACS罪犯病变VH-IVUS特点的相关性。结果超敏C反应蛋白浓度的中位数为3.66 mg/L,四分位数间距为2.21 mg/L。抵抗素浓度的中位数为3.53 mg/L,四分位数间距为6.28 mg/L。ACS患者血清抵抗素浓度与罪犯病变坏死核心体积绝对值呈正相关(r=0.427,P=0.01);ACS患者血清超敏C反应蛋白浓度与罪犯病变坏死核心体积绝对值也呈正相关(r=0.322,P=0.01)。结论 ACS患者血清超敏C反应蛋白及抵抗素浓度的增加都伴随着罪犯病变脂质池的扩大。血清抵抗素浓度在评价斑块易损性方面可能较血清超敏C反应蛋白浓度更加敏感。 Objective We analyse the relationship between plasma resistin and high-sensitive C reactive protein (hs-CRP) and the virtual histology intravascular ultrasound (VH-IVUS) characters of culprit lesions in acute coronary syndrome (ACS) patients, in order to know how plasma resistin and hs-CRP affect the plaque vulnerability. Method 60 ACS patients were included in our study. We used ELISA to analyse plasma resistin and hs-CRP. Culprit lesion was identified by analyzing ST-T alternation on electrocardiograms, left ventricular wall motion abnormalities, and angiographic complex lesions. We performed VH-IVUS examination on each culprit lesion and analyzed the relationship between plasma resistin, hs-CRP and the VH-IVUS characters of the culprit leision. Result Plasma resistin (median: 3.53 mg/L; interquartile range: 6.28 mg/L) was positively associated with the absolute volume of necrotic core (r=0.427, P=0.01 ) and it was statistically significant. Plasma hs-CRP (median: 3.66 mg/L; interquartile range: 2.21 mg/L) was positively associated with the absolute volume of necrotic core (r=0.322, P=0.01 ) and it was statistically significant either. Coneusion The increase of plasma resistin was related to the increase of vulnerability of culprit leision in ACS patients. Plasma resistin might be more sensitive than plasma hr-CRP when evaluated the plaque vulnerability.
出处 《中国介入心脏病学杂志》 2014年第1期30-34,共5页 Chinese Journal of Interventional Cardiology
基金 2012年广东省科技计划项目(2012B031800272)
  • 相关文献

参考文献13

  • 1Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol, 1998, 18:1386-1392.
  • 2Yasojima K, Schwab C, McGeer EG, et al. C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol, 2001, 158:1039-1051.
  • 3Ishikawa T, Imamura T, Hatakeyama K, et al. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation. Am J Cardiol, 2004, 93:611-614.
  • 4Ishikawa T, Hatakeyama K, Imamura T, et al. Involvement of C-reactive protein obtained by directional coronary athereetomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol, 2003, 91:287-292.
  • 5Kobayashi S, Inoue N, Ohashi Y, et al. Interaction of Oxidative stress and inflammatory response in coronary plaque instability:important role of C-reactive protein. Arterioscler Thromb Vasc Biol, 2003, 23:1398-1404.
  • 6Lubos E, Messow CM, Schnabel R, et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis, 2007, 193:121-128.
  • 7Otake H, Shite J, Shinke T, et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol, 2008, 101:1-7.
  • 8Patel L, Buckels AC, Kinghorn I J, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun, 2003, 300:472-476.
  • 9Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 2005, 111:932-939.
  • 10Lehrke M, Reilly MP, Millington SC, et al. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med, 2004, 1:e45.

二级参考文献17

  • 1Steppan CM,Bailey ST,Bhat S,et al.The hormone resistin links obesity to diabetes.Nature,2001,409:307-312.
  • 2Burnett MS,Lee CW,Kinnaird TD,et al.The potential role of resisitn in atherosclerosis.Atherosclerosis,2005,182:241-248.
  • 3Ohmori R,Momiyama Y,Kato R,et al.Associations between resistin levels and insulin resistance,inflammation,and coronary artery disease.JACC,2005,46:379-380.
  • 4Reilly MP,Lehrke M,Wolfe ML,et al.Resistin is an inflammatory marker of atherosclerosis in humans.Circulation,2005,111:932-939.
  • 5Tuttle KT,Short RA,Johnson RJ.Sex differences in uric acid and risk factors for coronary artery disease.Am J Cardiol,2001,87:1411-1414.
  • 6Katz A,Nambi SS,Mather K,et al.Quantitative insulin sensitivity check index:A simple,accurate method for assessing insulin sensitivity in humans.J Clin Endocrinol Metab,2000,85:2402-2410.
  • 7Hrebícek J,Janout V,Malincíkov J,et al.Detection of Insulin Resistance by Simple Quantitative Insulin Sensitivity Check Index QUICKI for Epidemiological Assessment and Prevention.J Clin Endocrinol Metab,2002,87:144-147.
  • 8Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia,1985,28:412-419.
  • 9McTernan PG,Fisher FM,Valsamakis G,et al.Resistin and type 2 diabetes:regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.J Clin Endocrinol Metab,2003,88:6098-6106.
  • 10Pagano C,Marin O,Calcagno A,et al.Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance.J Clin Endocrinol Metab,2005,90:4335-4340.

共引文献4

同被引文献85

引证文献9

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部